Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
75
BCS Quote, Financials, Valuation and Earnings
Last price:
$19.03
Seasonality move
:
1.96%
Day range:
$18.48 - $18.76
52-week range:
$10.23 - $18.82
Dividend yield:
2.34%
P/E ratio:
9.49x
P/S ratio:
1.99x
P/B ratio:
0.68x
Volume:
31.6M
Avg. volume:
15.3M
1-year change:
57.4%
Market cap:
$66.1B
Revenue:
$33.5B
EPS (TTM):
$1.97
Analysts' Opinion
-
Consensus RatingBarclays PLC has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $18.05, Barclays PLC has an estimated downside of -3.63% from its current price of $18.73.
-
Price Target UpsideAccording to analysts, the highest upside price target is $19.80 representing -100% upside increase from its current price of $18.73.
Fair Value
-
According to the consensus of 2 analysts, Barclays PLC has -3.63% downside to fair value with a price target of $18.05 per share.
BCS vs. S&P 500
-
Over the past 5 trading days, Barclays PLC has overperformed the S&P 500 by 0.47% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Barclays PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Barclays PLC has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Barclays PLC reported revenues of $9.7B.
Earnings Growth
-
Barclays PLC has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Barclays PLC reported earnings per share of $0.65.
Enterprise value:
-99.8B
EV / Invested capital:
--
Price / LTM sales:
1.99x
EV / EBIT:
-9.16x
EV / Revenue:
-2.90x
PEG ratio (5yr expected):
0.20x
EV / Free cash flow:
-0.48x
Price / Operating cash flow:
0.22x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.42%
Net Income Margin (TTM):
24.44%
Return On Equity:
9.01%
Return On Invested Capital:
3.32%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $31.1B | $31.6B | $34.4B | $8.8B | $9.7B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.62 | $1.33 | $1.97 | $0.52 | $0.65 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $674.5B | $733.1B | $649.5B | $637.9B | $650.5B | |
| Total Assets | $1.9T | $2T | $1.9T | $2T | $2.1T | |
| Current Liabilities | $1.1B | $1.4B | $696M | $820.6M | $1.2B | |
| Total Liabilities | $1.8T | $1.9T | $1.8T | $1.9T | $2T | |
| Total Equity | $91B | $91.2B | $87.5B | $91.3B | $97.7B | |
| Total Debt | $141.9B | $160.6B | $156.9B | $150B | $143B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $29.9B | $47.4B | |
| Cash From Investing | -- | -- | -- | -$18.5B | -$20.6B | |
| Cash From Financing | -- | -- | -- | -$239.1M | $209.4M | |
| Free Cash Flow | $204.9B | $231B | $210B | $29.9B | $47.4B | |
BCS
Sector
Market Cap
$66.1B
$627.9M
Price % of 52-Week High
99.52%
89.42%
Dividend Yield
2.34%
1.97%
Shareholder Yield
--
4.06%
1-Year Price Total Return
57.4%
7.77%
Beta (5-Year)
1.099
0.585
Dividend yield:
2.34%
Annualized payout:
$0.42
Payout ratio:
--
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$18.52
200-day SMA
Buy
Level
$14.96
Bollinger Bands (100)
Buy
Level
15.06 - 17.98
Chaikin Money Flow
Buy
Level
1.2B
20-day SMA
Buy
Level
$18.25
Relative Strength Index (RSI14)
Buy
Level
59.69
ADX Line
Buy
Level
14.13
Williams %R
Sell
Level
-8.2576
50-day SMA
Buy
Level
$17.75
MACD (12, 26)
Buy
Level
0.28
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
590.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.669)
Sell
CA Score
(Annual)
Level (-2.4335)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.411)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; UK (retail), UK corporate bank, private bank and wealth management, investment bank, and US consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The international segment includes a corporate bank offering banking solutions to large corporates, a bulge-bracket global investment bank, and a credit card and payments business.
Stock Forecast FAQ
In the current month, BCS has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BCS average analyst price target in the past 3 months is $18.05.
-
Where Will Barclays PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Barclays PLC share price will drop to $18.05 per share over the next 12 months.
-
What Do Analysts Say About Barclays PLC?
Analysts are divided on their view about Barclays PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Barclays PLC is a Sell and believe this share price will rise from its current level to $16.30.
-
What Is Barclays PLC's Price Target?
The price target for Barclays PLC over the next 1-year time period is forecast to be $18.05 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BCS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Barclays PLC is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of BCS?
You can purchase shares of Barclays PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Barclays PLC shares.
-
What Is The Barclays PLC Share Price Today?
Barclays PLC was last trading at $19.03 per share. This represents the most recent stock quote for Barclays PLC. Yesterday, Barclays PLC closed at $18.73 per share.
-
How To Buy Barclays PLC Stock Online?
In order to purchase Barclays PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
